159 related articles for article (PubMed ID: 10395408)
21. High serum levels of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in patients with carcinoid tumors.
Klootwijk W; de Herder WW; Kwekkeboom DJ; Lamberts SW; Krenning EP; Visser TJ; de Greef WJ
J Clin Endocrinol Metab; 1996 Aug; 81(8):2816-20. PubMed ID: 8768836
[TBL] [Abstract][Full Text] [Related]
22. Renal clearance of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in humans.
Klootwijk W; Sleddens-Linkels E; de Boer R; Jansen CA; Autar R; de Herder WW; Boevé ER; Visser TJ; de Greef WJ
J Clin Endocrinol Metab; 1997 Sep; 82(9):3068-73. PubMed ID: 9284745
[TBL] [Abstract][Full Text] [Related]
23. TRH-related peptides in the rabbit prostate complex during development.
Thetford CR; Morrell JM; Cockle SM
Biochim Biophys Acta; 1992 Jan; 1115(3):252-8. PubMed ID: 1739740
[TBL] [Abstract][Full Text] [Related]
24. Gonadal steroids regulate rat anterior pituitary levels of TSH-releasing hormone- and pyroglutamyl-glutamyl-proline amide-like immunoreactivity.
Akinsanya KO; Ghatei MA; Bloom SR
Endocrinology; 1995 Feb; 136(2):734-40. PubMed ID: 7835305
[TBL] [Abstract][Full Text] [Related]
25. Cerebrovascular effects of the TRH analogues pGlu-3-methyl-His-Pro amide and pGlu-Glu-Pro amide: a comparison with TRH.
Koskinen LO; Koch ML; Svedberg J
Ups J Med Sci; 2000; 105(1):73-83. PubMed ID: 10893055
[TBL] [Abstract][Full Text] [Related]
26. Thyroid hormone modulation of thyrotrophin-releasing hormone (TRH) and TRH-Gly levels in the male rat reproductive system.
Pekary AE; Bhasin S; Smith V; Sugawara M; Swerdloff RS; Hershman JM
J Endocrinol; 1987 Aug; 114(2):271-7. PubMed ID: 3116140
[TBL] [Abstract][Full Text] [Related]
27. TRH-like antidepressant peptide, pyroglutamyltyroslyprolineamide, occurs in rat brain.
Eugene Pekary A; Faull KF; Paulson M; Lloyd RL; Sattin A
J Mass Spectrom; 2005 Sep; 40(9):1232-6. PubMed ID: 16124040
[TBL] [Abstract][Full Text] [Related]
28. Evidence for interplay between thyrotropin-releasing hormone (TRH) and its structural analogue pGlu-Glu-Pro-NH2 ([Glu2]TRH) in the brain: an in vivo microdialysis study.
Nguyen V; Zharikova AD; Prokai L
Neurosci Lett; 2007 Mar; 415(1):64-7. PubMed ID: 17234338
[TBL] [Abstract][Full Text] [Related]
29. Peptides related to thyrotrophin-releasing hormone (TRH) in human prostate and semen.
Cockle SM; Prater GV; Thetford CR; Hamilton C; Malone PR; Mundy AR
Biochim Biophys Acta; 1994 Oct; 1227(1-2):60-6. PubMed ID: 7522575
[TBL] [Abstract][Full Text] [Related]
30. Expression of prostatic TRH-like peptides differs between species and between malignant and nonmalignant tissues.
Gkonos PJ; Kwok CK; Block NL; Roos BA
Prostate; 1993; 23(2):135-47. PubMed ID: 7690955
[TBL] [Abstract][Full Text] [Related]
31. Processing of the thyrotropin releasing hormone (TRH) precursor in Xenopus skin and bovine hypothalamus: evidence for the existence of extended forms of TRH.
Cockle SM; Smyth DG
Regul Pept; 1986 May; 14(3):217-27. PubMed ID: 3088682
[TBL] [Abstract][Full Text] [Related]
32. Circadian rhythms of TRH-like peptide levels in rat brain.
Pekary AE; Stevens SA; Sattin A
Brain Res; 2006 Dec; 1125(1):67-76. PubMed ID: 17113044
[TBL] [Abstract][Full Text] [Related]
33. Role of TRH receptors as possible mediators of analeptic actions of TRH-like peptides.
Hinkle PM; Pekary AE; Senanayaki S; Sattin A
Brain Res; 2002 May; 935(1-2):59-64. PubMed ID: 12062473
[TBL] [Abstract][Full Text] [Related]
34. High concentrations of p-Glu-His-Pro-NH2 (thyrotropin-releasing hormone) occur in rat prostate.
Pekary AE; Sharp B; Briggs J; Carlson HE; Hershman JM
Peptides; 1983; 4(6):915-9. PubMed ID: 6324143
[TBL] [Abstract][Full Text] [Related]
35. Evidence of thyrotropin-releasing hormone (TRH) gene expression in rat anterior pituitaries and modulation by estrogens of TRH-like immunoreactivity and TRH-elongated peptide contents.
Croissandeau G; Schussler N; Grouselle D; Pagesy P; Rauch C; Bayet MC; Peillon F; Le Dafniet M
J Endocrinol; 1996 Oct; 151(1):87-96. PubMed ID: 8943772
[TBL] [Abstract][Full Text] [Related]
36. Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus.
Diano S; Naftolin F; Goglia F; Horvath TL
Endocrinology; 1998 Jun; 139(6):2879-84. PubMed ID: 9607797
[TBL] [Abstract][Full Text] [Related]
37. The effects of pyroglutamylglutamylprolineamide, a peptide related to thyrotrophin-releasing hormone, on rat anterior pituitary cells in culture.
Ashworth RJ; Ham J; Cockle SM
J Endocrinol; 1994 Jul; 142(1):111-8. PubMed ID: 7964269
[TBL] [Abstract][Full Text] [Related]
38. Effects of hypo- and hyperthyroidism on pancreatic TRH-degrading activity and TRH concentrations in developing rat pancreas.
Aratan-Spire S; Wolf B; Czernichow P
Acta Endocrinol (Copenh); 1984 Jun; 106(2):209-14. PubMed ID: 6428122
[TBL] [Abstract][Full Text] [Related]
39. Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
Denereaz N; Lemarchand-Beraud T
Endocrinology; 1995 Apr; 136(4):1694-700. PubMed ID: 7895680
[TBL] [Abstract][Full Text] [Related]
40. Electroconvulsive seizures modulate levels of thyrotropin releasing hormone and related peptides in rat hypothalamus, cingulate and lateral cerebellum.
Pekary AE; Meyerhoff JL; Sattin A
Brain Res; 2000 Nov; 884(1--2):174-83. PubMed ID: 11082499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
